Europe — EMA
Obradon (Atorvastatin)
Atorvastatin, the active ingredient in Obradon, is a HMG‑CoA reductase inhibitor presented as a tablet for oral use. It lowers elevated cholesterol and triglyceride levels in adults at risk for cardiovascular disease.
Request sourcing
What is Atorvastatin?
Atorvastatin, the active ingredient in Obradon, is a HMG‑CoA reductase inhibitor presented as a tablet for oral use. It lowers elevated cholesterol and triglyceride levels in adults at risk for cardiovascular disease. GNH USA supplies Obradon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Obradon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Atorvastatin used for?
Obradon is a lipid‑lowering agent that acts on the cholesterol synthesis pathway. It is used in several clinically recognised : - Hypercholesterolemia: Reduces low‑density lipoprotein (LDL) cholesterol and total cholesterol levels. - Familial hypercholesterolaemia (heterozygous): Improves LDL‑C control in patients with genetic elevated LDL cholesterol. - Primary primary primary primary by . - . - . - . - . - . - ... . - . - " " " " " " "" "" ". - " ".
What are the side effects of Atorvastatin?
The ... … ... ...
What precautions apply to Atorvastatin?
...
